Filing Details
- Accession Number:
- 0001104659-22-119642
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-16 19:01:03
- Reporting Period:
- 2022-11-15
- Accepted Time:
- 2022-11-16 19:01:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1722964 | Y-Mabs Therapeutics Inc. | YMAB | Pharmaceutical Preparations (2834) | 474619612 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1815042 | Vignesh Rajah | C/O Y-Mabs Therapeutics, Inc. 230 Park Avenue Suite 3350 New York NY 10169 | Svp & Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-11-15 | 1,195 | $4.92 | 4,266 | No | 4 | P | Indirect | Spouse and minor |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Spouse and minor |
Footnotes
- Includes 4,033 shares of common stock owned by Reporting Person's spouse and 233 held by Reporting Person's minor child. Reporting Person may be deemed to have a pecuniary interest in the securities due to family relationship.
- Reporting Person disclaims beneficial ownership of the securities reported and this report shall not be deemed an admission that Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act, as amended, or for any other purpose.